it's been a nice little boost for s/holders with the addition of Manuel and Fabian's conservations and SIOI increased commercial deal in the newsroom
not a good year for the sp or dilution to s/holders but the anteo team have developed the company significantly this year.
the team they have built with defined roles
protecting the ip
building anteox and anteobind production facilities (with plans of expansion)
increasing testing ability
$5.4m in govt grants
expanding partnerships in both divisions
naming mercedes and getting orders for anteox and ultranode
being able to build a significant database for CET and life science divisons. and in doing so getting independent research to support and back up in house results
recognising the need for anteobind NXT with it's costing and comparison vs EDC/NHS tech. and then recognising the growth potential in India. and getting our 1st deal with SIOI
expanding CET revenue potential with separator and CNT work
I was really happy with Fabian when he said that "same for Anteotech in europe, whenever something is required to expand business, to set up new things, to be close to the customer"
anteotech have claimed that they will have an office in europe. they have the guy to set it up, ready to go in the new year. IMO, it's not just going to be a sales office. with the 80k -100k litre production facility in Australia, how much more production will anteotech need. and if plans for European expansion are underway, what does that say about the future demand of anteoX and ultranode and then what future valuation of ADO.
GLTAH !!!!!!!
ps "im allowed to have a voice".
(20min delay)